NMRA - Neumora Therapeutics, Inc.

Insider activity in NMRA over the last quarter tilts toward selling: insiders offloaded a net 453,833 shares worth roughly $702K.

NMRA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Berns Paul L	7.40M	$25.95M	-
Pres	Pinto Joshua	57.8K	$204.3K	-
Other	Milligan Michael Lee	21.0K	$75.0K	-
Other	Aurora Daljit Singh	0	-	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 26, 2024	Pinto Joshua74	Chief Financial Officer	Sell10b5-1	84,307	$11.67	$984,061.15	-35.3%	-17.4%	-85.1%
Nov 14, 2023	Arch Venture Partners Xii, LLC62	10% Owner	Buy	35,010	$11.77	$412,139.61	+0.9%	+52.3%	-9.1%
Nov 14, 2023	Burow Kristina66	Director, 10% Owner	Buy	35,010	$11.77	$412,139.61	+0.9%	+52.3%	-9.1%
Nov 10, 2023	Arch Venture Partners Xii, LLC62	10% Owner	Buy	140,605	$10.98	$1,543,563.42	+3.6%	+50.7%	+16.9%
Nov 10, 2023	Burow Kristina66	Director, 10% Owner	Buy	140,605	$10.98	$1,543,563.42	+3.6%	+50.7%	+16.9%
Nov 7, 2023	Arch Venture Partners Xii, LLC62	10% Owner	Buy	95,694	$11.49	$1,099,944.70	+2.5%	+30.9%	+9.6%
Nov 7, 2023	Burow Kristina66	Director, 10% Owner	Buy	95,694	$11.49	$1,099,944.70	+2.5%	+30.9%	+9.6%
Sep 29, 2023	Arch Venture Partners Xii, LLC62	10% Owner	Buy	76,511	$13.68	$1,046,848.16	+2.0%	+21.5%	-8.4%
Sep 29, 2023	Burow Kristina66	Director, 10% Owner	Buy	76,511	$13.68	$1,046,848.16	+2.0%	+21.5%	-8.4%
Sep 27, 2023	Arch Venture Partners Xii, LLC62	10% Owner	Buy	58,504	$11.97	$700,464.24	+1.6%	+48.1%	+10.7%